Related Experiment Videos

Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines

A Merzak1, S Raynal, J P Rogers

  • 1Department of Neuropathology, Institute of Psychiatry, Denmark Hill, London, UK.

Insights

The wild-type p53 gene suppressed growth and induced differentiation in human astrocytoma cell lines, regardless of tumor grade. This indicates p53

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Astrocytomas are primary brain tumors with varying grades of malignancy.
  • The p53 gene is a critical tumor suppressor, but its role in astrocytomas of different grades requires further elucidation.
  • Understanding p53's function is crucial for developing targeted therapies for brain tumors.

Purpose of the Study:

  • To investigate the tumor suppressor role of the wild-type p53 gene in human astrocytoma cell lines of varying grades.
  • To determine if p53 influences cell morphology and differentiation in these cell lines.
  • To assess the mechanism of p53-mediated growth inhibition, specifically whether it involves apoptosis.

Main Methods:

  • Transfection of pilocytic astrocytoma, grade III astrocytoma, and glioblastoma cell lines with the human wild-type p53 gene.
  • Assessment of cell growth inhibition and morphological changes post-transfection.
  • Analysis to determine if growth inhibition was mediated by apoptosis induction.

Main Results:

  • The p53 gene demonstrated a significant growth suppressor effect across all tested astrocytoma cell lines, irrespective of their grade.
  • p53 transfection induced notable morphological alterations, promoting a differentiated astrocyte phenotype (flat, large cell body, stellate shape with long processes).
  • The observed growth inhibition by p53 was not attributed to the induction of apoptosis.

Conclusions:

  • The p53 gene functions as a tumor suppressor in both low-grade and high-grade human astrocytomas.
  • p53 may play a role in promoting glioma cell differentiation in vitro.
  • These findings highlight the therapeutic potential of p53 in managing astrocytomas.

Related Concept Videos